Haleon (LON:HLN) Releases Quarterly Earnings Results

Haleon (LON:HLN) issued its quarterly earnings data on Friday. The company reported GBX 15.80 ($0.20) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Haleon had a net margin of 9.66% and a return on equity of 6.54%.

Haleon Price Performance

Shares of HLN opened at GBX 395.30 ($4.97) on Friday. The firm has a market capitalization of £35.68 billion, a PE ratio of 33.25, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 53.36, a current ratio of 0.84 and a quick ratio of 0.93. Haleon has a 1-year low of GBX 308.37 ($3.88) and a 1-year high of GBX 402.30 ($5.06). The company’s fifty day moving average price is GBX 379.73 and its 200-day moving average price is GBX 379.15.

Haleon Company Profile

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.